tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (30%), 1 are a HOLD (10%), 6 are a BUY (60%).
Analyst Lyanne Harrison, currently employed at BAML, carries an average stock price target met ratio of 50% that have a potential upside of 14.8% achieved within 138 days.
Lyanne Harrison’s has documented 20 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 25-Sep-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $13.26 (6.86%) receiving and performance score of 22.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$330
$58 (21.32%)
$285
1 months ago
(17-Sep-2025)
7/8 (87.5%)
$56.71 (20.75%)
38
Buy
$270
$-2 (-0.74%)
$250
3 months 2 days ago
(15-Jul-2025)
14/14 (100%)
$16.28 (6.42%)
98
Buy
$290
$18 (6.62%)
5 months 24 days ago
(23-Apr-2025)
17/17 (100%)
$54.9 (23.35%)
363
Hold
$248
$-24 (-8.82%)
$260
5 months 24 days ago
(23-Apr-2025)
3/3 (100%)
$12.9 (5.49%)
70
Hold
$240
$-32 (-11.76%)
$250
7 months 13 days ago
(04-Mar-2025)
2/2 (100%)
$17.12 (7.68%)
54
What Year was the first public recommendation made by Lyanne Harrison?
